Winning sectors like coal have taken a hit. Who's on top now?   Read More

Medicis Pharma could have such a product on the market by 2011.   Read More

I noted yesterday the miserably bearish mood Wall Street has been in recently. The market has been having problems because the central assumption of bulls--that the second half of the year would see a rebound in earnings--is coming under attack. As a result, traders have been taking every opportunity to sell into rallies in June.    Read More

Plus, two more international stock picks from Cramer.   Read More

The market can swing as much on sentiment as fact. Investors would be wise to remember this.   Read More

As Israel celebrates 60 years of statehood, American investors may be looking to invest in shares of Israeli companies.  Haim Israel of Merrill Lynch in Jerusalem has some ideas about smaller companies that may have escaped the attention of U.S. investors.    Read More

If so, Cramer says it could be a great move for this company.   Read More

Wall Street’s on the edge of its seat ahead of Wednesday’s interest-rate announcement. You should be on the phone with your broker.   Read More

Genentech stock is on a tear this year and analysts are expecting double-digit sales growth for most of the biotech's key drugs this quarter. Can Genentech keep it up?   Read More

He's expecting a full recovery – and more – for this company.   Read More